OCD breakthrough? Anti-Inflammatory drug targets brain inflammation in new study
NCT ID NCT04786548
First seen Nov 05, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This study looked at whether measuring brain inflammation with scans and blood tests could predict how much people with obsessive-compulsive disorder (OCD) would benefit from adding the anti-inflammatory drug celecoxib to their current medication. The goal was to see if a personalized approach could improve OCD symptoms. The study was suspended and enrolled 21 adults aged 18-55 with ongoing OCD symptoms despite treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
New York State Psychiatric Institute
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.